Bill Wexler's Profits of DOOM Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Bill Wexler's Profits of DOOM

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bill Wexler who wrote ()	2/23/1998 11:18:00 AM
From: Bill Wexler	Read Replies (1) of 4634

Zonagen continues to defraud investors Zonagen is a fraudulent scheme to separate small investors from their money by falsely claiming that they have a drug that treats male erectile disfunction. The drug's name is Vasomax. Zonagen has never delivered revenues, earnings, or even halfway viable products. Vasomax's only active ingredient is Phentolamine. Phentolamine does not produce erections nor does it help treat ED in any way. Zonagen's management has knowingly and repeatedly lied in press releases. Zonagen's management has lied about its clinical test results. Zonagen's management tried to rig the clinical trails and conducted them improperly. Zonagen's management has also been involved in spreading false rumors on internet chat forums. There is absolutely no value in Zonagen's stock except the cash they have in the bank. Zonagen does not have the research and development infrastructure necessary to bring any drug to market. Zonagen claims to have a unique, fast-acting formula for an oral phentolamine tablet (Vasomax). This formula is not unique, and is not patentable. Zonagen has lied repeatedly claiming that patent protection was a certainty. Zonagen's management and several of it's paid promoters...particularly McGarr Capital, have been involved in stock manipulation and fraud. McGarr Capital has issued several false and misleading research reports knowing that the reports contained misleading statements and outright fabrications. Zonagen's management has a history of criminal and unethical behavior. The most recent example was their attempt to market a drug called Immumax, which was a direct rip-off of an existing product called Chitosan. Zonagen's stock will soon trade in the single digits, and should not be bought or held.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next